Mather Group’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-270
| Closed | -$8.84K | – | 1595 |
|
|
2025
Q1 | $8.84K | Buy |
270
+160
| +145% | +$5.24K | ﹤0.01% | 1284 |
|
|
2024
Q4 | $3.98K | Hold |
110
| – | – | ﹤0.01% | 1416 |
|
|
2024
Q3 | $3.43K | Sell |
110
-140
| -56% | -$4.37K | ﹤0.01% | 1368 |
|
|
2024
Q2 | $8.53K | Hold |
250
| – | – | ﹤0.01% | 1492 |
|
|
2024
Q1 | $7.24K | Buy |
+250
| New | +$7.24K | ﹤0.01% | 1278 |
|